We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




General Anesthesia Improves Post-Surgery Outcomes for Acute Stroke Patients

By HospiMedica International staff writers
Posted on 01 Dec 2025

When treating acute ischemic stroke with mechanical thrombectomy, clinicians traditionally rely on moderate sedation to keep patients awake yet comfortable. More...

Now, new evidence suggests that placing patients under general anesthesia may lead to better long-term recovery.

This finding comes from a randomized, controlled, multicenter clinical trial led by UTHealth Houston (Houston, TX, USA), marking the first rigorous comparison of anesthesia strategies during the procedure. In the study published in JAMA Neurology, the team studied 260 individuals undergoing thrombectomy, a procedure in which surgeons thread a catheter from the groin to the brain and remove the clot causing the stroke.

Participants were randomly assigned to receive general anesthesia or moderate sedation. After three months, patients in the general anesthesia group showed better neurological outcomes than those sedated moderately. This was notable because prior observational studies had not identified differences in recovery based on anesthesia type. The team’s research is particularly novel because they used a statistical model to focus on a practical sample size.

“About 60 to 70% of the patients who have the thrombectomy return to normal or near normal life. But there’s still about 30 to 40% of patients that might still live with neurological deficits or die. Every step of the thrombectomy can be optimized to improve the outcome of stroke therapy,” said principal investigator Peng Roc Chen, MD. “Hopefully, this will be a wake-up call to change the treatment guidelines.”

Related Link
UTHealth Houston


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.